Le produit a bien été ajouté au panier.

discount label
H-SL^YNTVATL-OH
Vue en 3D

Biosynth logo

H-SL^YNTVATL-OH

Ref. 3D-PP41703

Taille indéfinieÀ demander
Livraison estimée en/au États-Unis, le mercredi 16 octobre 2024

Informations sur le produit

Nom :
H-SL^YNTVATL-OH
Description :

Peptide H-SL^YNTVATL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SL^YNTVATL-OH include the following: Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. TJ Tsomides, A Aldovini , RP Johnson - The Journal of , 1994 - rupress.orghttps://rupress.org/jem/article-abstract/180/4/1283/25381 Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual T Harrer, E Harrer, P Barbosa, F Kaufmann - The Journal of , 1998 - journals.aai.orghttps://journals.aai.org/jimmunol/article/161/9/4875/31899 Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance S Tenzer , E Wee, A Burgevin, G Stewart-Jones - Nature , 2009 - nature.comhttps://www.nature.com/articles/ni.1728 Amino acid similarity accounts for T cell cross-reactivity and for"holes" in the T cell repertoire S Frankild, RJ De Boer , O Lund , M Nielsen , C Kesmir - PloS one, 2008 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001831 Theoretical Dynamics and Energetics of HLA-A2/SLYNTVATL Interaction O Olaposi, H Tsuyoshi - American Journal of Bioinformatics Research, 2015 - academia.eduhttps://www.academia.edu/download/70861651/10.5923.j.bioinformatics.20150501.01.pdf MHC Class I Molecules with NA CTLs, SCD Binding - J. Immunol, 2010 - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=f8202eb4619e178604accb92076d32557c5daa64 MHC Class I Molecules with Superenhanced NA CTLs - 2010 - researchgate.nethttps://www.researchgate.net/profile/Rachel-Hewitt-6/publication/41622720_MHC_Class_I_Molecules_with_Superenhanced_CD8_Binding_Properties_Bypass_the_Requirement_for_Cognate_TCR_Recognition_and_Nonspecifically_Activate_CTLs/links/0c9605208d6e41f38a000000/MHC-Class-I-Molecules-with-Superenhanced-CD8-Binding-Properties-Bypass-the-Requirement-for-Cognate-TCR-Recognition-and-Nonspecifically-Activate-CTLs.pdf Accurate structure prediction of peptide-MHC complexes for identifying highly immunogenic antigens MS Park, SY Park, KR Miller, EJ Collins, HY Lee - Molecular immunology, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0161589013001545 Suboptimal stimulation by weak agonist epitope variants does not drive dysfunction of HIV-1-specific cytotoxic T lymphocyte clones MA Grossman , C Hofmann , HL Ng, OO Yang - AIDS, 2019 - journals.lww.comhttps://journals.lww.com/aidsonline/FullText/2019/08010/Suboptimal_stimulation_by_weak_agonist_epitope.3.aspx Competition among peptides in melanoma vaccines for binding to MHC molecules LW Thompson, CF Garbee, S Hibbitts - Journal of , 2004 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2004/11000/competition_among_peptides_in_melanoma_vaccines.2.aspx T cell cross-reactivity and conformational changes during TCR engagement JK Lee, G Stewart-Jones, T Dong , K Harlos - The Journal of , 2004 - rupress.orghttps://rupress.org/jem/article-abstract/200/11/1455/54291 Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent JA Whelan, P Dunbar , DA Price - The Journal of , 1999 - journals.aai.orghttps://journals.aai.org/jimmunol/article/163/8/4342/32436 The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope J Kan-Mitchell, B Bisikirska , F Wong-Staal - The Journal of , 2004 - journals.aai.orghttps://journals.aai.org/jimmunol/article/172/9/5249/72181 Peptides for vaccine development IW Hamley - ACS Applied Bio Materials, 2022 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsabm.1c01238 Characterization of MHC ligands for peptide based tumor vaccination F Klug, M Miller, HH Schmidt - Current pharmaceutical , 2009 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpd/2009/00000015/00000028/art00003 Structural basis for degenerate recognition of natural HIV peptide variants by cytotoxic lymphocytes E Martinez-Hackert , N Anikeeva , SA Kalams - Journal of biological , 2006 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)76335-2/abstract Dual molecular mechanisms govern escape at immunodominant HLA A2-restricted HIV epitope DK Cole , A Fuller, G Dolton , E Zervoudi - Frontiers in , 2017 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2017.01503/full Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes DA Price, AK Sewell , T Dong , R Tan , PJR Goulder - Current biology, 1998 - cell.comhttps://www.cell.com/current-biology/pdf/S0960-9822(98)70138-1.pdf A mAb against HLA-A2 can be influenced both positively and negatively by the associated peptide D Barouch , M Davenport , A McMichael - International , 1995 - academic.oup.comhttps://academic.oup.com/intimm/article-abstract/7/10/1599/714190 High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection CA Jansen, S Kostense - European journal of , 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200425487 Random screening of proteins for HLA-A* 0201-binding nine-amino acid peptides is not sufficient for identifying CD8 T cell epitopes recognized in the context of HLA C Pelte, G Cherepnev, Y Wang - The Journal of , 2004 - journals.aai.orghttps://journals.aai.org/jimmunol/article/172/11/6783/80929 Discovery and characterization of highly immunogenic and broadly recognized mimics of the HIV-1 CTL epitope Gag77-85 C Boggiano , R Moya, C Pinilla , F Bihl - European journal of , 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200425903 Recognition of Two Overlapping CTL BD Walker , MF Kalden, RP Johnson, S Buchbinder - J Immunol, 1998 - academia.eduhttps://www.academia.edu/download/38282868/4875.pdf Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope AKN Iversen, G Stewart-Jones, GH Learn - Nature , 2006 - nature.comhttps://www.nature.com/articles/ni1298 Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides AK Sewell , GC Harcourt, PJR Goulder - European journal of , 1997 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830270929 Differential processing of HLA A2-restricted HIV type 1 cytotoxic T lymphocyte epitopes AK Sewell , BL Booth Jr, V Cerundolo, RE Phillips - Viral , 2002 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/088282402317340332 Cross-reactivity between influenza matrix-and HIV-1 P17-specific CTL-a large cohort study AG Huckelhoven, JK Etschel, S Bergmann - JAIDS Journal of , 2015 - journals.lww.comhttps://journals.lww.com/jaids/fulltext/2015/08150/cross_reactivity_between_influenza_matrix__and.3.aspx Receptor Binding by Cholera Toxin B-Subunit and Amino Acid Modification Improves Minimal Peptide Immunogenicity A Boberg, A Staca¥lnacke, A Braca¥ve - International , 2012 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.5402/2012/170676

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP41703 H-SL^YNTVATL-OH

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".